The 2020 American College of Cardiology Expert Consensus Decision Pathway provides a change in mindset for the cardiology field when it comes to treating patients with type 2 diabetes with established cardiovascular disease. Here to walk us through these updated recommendations is Dr. Joshua Stolker, an interventional cardiologist at Mercy Clinic Heart and Vascular in Saint Louis, Missouri.

To view the 2020 American College of Cardiology Expert Consensus Decision Pathway click here.

Novo Nordisk is a registered trademark of Novo Nordisk A/S.

© 2021 Novo Nordisk All rights reserved. US20DI00430 January 2021

Affecting one in every 10,000 births worldwide, spinal muscular atrophy, also known as SMA, can result in the progressive loss of basic muscle function and in its most severe forms, can lead to death or the need for permanent ventilation in 90% of cases by age two. How can we help ensure that patients with this debilitating disease get diagnosed early, and what role does gene therapy play in its treatment? Tune in as Dr. Chamindra Konersman from Rady Children’s Hospital in San Diego discusses that and more with Dr. Kevin Strauss from the Clinic for Special Children in Pennsylvania.

© 2021 Novartis Gene Therapies, Inc. US-ZOL-20-0544 1/2021

For the millions of Americans living with acne, the conversation has been primarily focused on facial acne, overlooking other areas of the body. That’s why it’s so important to ask the right questions about a patient’s acne—even the acne we can’t see—in addition to offering solutions for achieving clearer skin on the face and trunk, as Dr. Mona Gohara explains.

IMPORTANT SAFETY INFORMATION (ISI)

INDICATION: AKLIEF® (trifarotene) Cream, 0.005% is a retinoid indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. ADVERSE EVENTS: The most common adverse reactions (incidence ≥ 1%) in patients treated with AKLIEF Cream were application site irritation, application site pruritus (itching), and sunburn. WARNINGS/PRECAUTIONS: Patients using AKLIEF Cream may experience erythema, scaling, dryness, and stinging/burning. Use a moisturizer from the initiation of treatment, and, if appropriate, depending upon the severity of these adverse reactions, reduce the frequency of application of AKLIEF Cream, suspend or discontinue use. Avoid application of AKLIEF Cream to cuts, abrasions or eczematous or sunburned skin. Use of “waxing” as a depilatory method should be avoided on skin treated with AKLIEF Cream. Minimize exposure to sunlight and sunlamps. Use sunscreen and protective clothing over treated areas ...

Cervical cancer is the fourth most common cancer in women worldwide, which makes it essential for us to keep ahead of advances in cervical cancer prevention—advances like a biomarker-based cytology test. Here to discuss this and other recent advancements in cervical cancer screening is Dr. Lee Shulman, the Anna Ross Lapham Professor in Obstetrics and Gynecology in the Division of Clinical Genetics at the Feinberg School of Medicine at Northwestern University.

Exacerbations are something that many patients with chronic obstructive pulmonary disease (COPD) may experience at some point in their journey. Explore how COPD exacerbations can impact patients as well as how a treatment option may help with Danielle Dolan, RN, MS, NP-C, AE-C, a respiratory and immunology Clinical Science Liaison with AstraZeneca.

Multiple sclerosis (MS) patient advocacy groups have been at the forefront of the COVID-19 pandemic, uncovering the unmet needs of patients during this crisis and creating platforms for discussion and tools to mitigate some of these needs. In fact, they’re the resource providers for newly diagnosed and current MS patients.

That’s why this virtual webinar taken from a live broadcast features a panel representing five patient advocacy societies to discuss the impact of COVID-19 and the evolving "new normal" by elaborating on the current unmet patient needs and discussing the mutually exclusive initiatives and resources they are providing for patients and health care professionals to manage MS in the current environment.

12/20 M-NSF-1396183

Immune thrombocytopenia (ITP) is a heterogeneous disease characterized by unpredictable rates and severities of bleeding events, which complicate both its diagnosis and management. To help us overcome common challenges in ITP, Dr. James Bussel and Dr. Ralph Boccia join us to provide an overview of ITP, the diagnostic steps they recommend, and important treatment considerations through the care continuum.

©2020 Amgen Inc. All rights reserved. USA-531-80580 12/20

The addition of inflammatory markers to cardiovascular risk assessments is critical. Here to walk us through how we can better define patients at risk using this multi-marker approach beyond lipids are Drs. Atul Sachdev and Erminia Guarneri, hosted by Dr. Michael Roizen.

Small cell lung cancer is an aggressive form of lung cancer, and until recently therapeutic options have been limited. Joining Dr. Jennifer Caudle to discuss the role of immunotherapy in combination with chemotherapy in the treatment of this devastating disease as well as recent data from a clinical trial is Dr. Suma Satti, lung cancer specialist and Director of Chemo Infusion at Ochsner Medical Center in New Orleans.

Patients with acute myeloid leukemia (AML) are at high risk for febrile neutropenia or profound, protracted neutropenia. So how can we monitor for the risk of neutropenia in AML patients starting venetoclax therapy? That’s what Ilene Galinsky, Senior Program Research Nurse Practitioner for the Leukemia Program at Dana Farber Cancer Institute, is here to explain.